AIMDW · Ainos, Inc. · Documents
$0.06
+0.00 (+0.00%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 3, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Although management expects the Company will continue as a going concern, there is no assurance that management's plans will be successful since the availability and amount of such funding is not certain. Accordingly, substantial doubt exists about the Company's ability to continue as a going concern for at least one year from the issuance of these financial statements.”View the 10-Q filed Aug 3, 2026
Market Cap
$5.78M
Shares
7.38M
Volume · Oct 26
1811
Avg daily vol (3M)
6784
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Ainos, Inc.'s board on October 14, 2026 unanimously approved second amended and restated bylaws adopting a classified board with three classes and amended Corporate Governance Policies reflecting that structure. | 2026-10-16 | 2026-10-14 | |
| 8-K | Ainos, Inc. granted BioPhoenix Co., Ltd. an exclusive, worldwide license for VELDONA® covering Sjögren’s Disease and Thrombocytopenia, with a $600,000 upfront fee, potential total license fees of approximately $10.0 million, and 25% of net sublicensing revenue. | 2026-09-28 | 2026-09-24 | |
| 10-Q | — | 2026-08-03 | 2026-06-30 | |
| 8-K | — | 2026-08-03 | — | |
| 8-K | — | 2026-07-10 | 2026-07-09 | |
| 8-K | — | 2026-07-09 | 2026-07-03 | |
| Investor Event Transcript | — | 2026-06-17 | 2026-06-30 | |
| 10-Q | — | 2026-05-13 | 2026-03-31 | |
| 8-K | — | 2026-05-13 | — | |
| 8-K | — | 2026-03-30 | — | |
| 10-K | — | 2026-03-30 | 2025-12-31 | |
| 8-K | — | 2026-01-06 | 2025-12-30 | |
| 8-K | — | 2026-01-05 | — | |
| 8-K | — | 2025-12-31 | 2025-12-30 | |
| 10-Q | — | 2025-11-13 | 2025-09-30 | |
| 8-K | — | 2025-11-13 | 2025-11-07 | |
| 8-K | — | 2025-10-17 | 2025-10-15 | |
| ARS | — | 2025-10-01 | 2024-12-31 | |
| DEF 14A | — | 2025-10-01 | — | |
| 8-K | — | 2025-09-08 | 2025-09-05 | |
| 8-K | — | 2025-08-13 | — | |
| 10-Q | — | 2025-08-13 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | 2025-08-06 | |
| 8-K | — | 2025-07-31 | — | |
| 8-K | — | 2025-07-16 | — | |
| 8-K | — | 2025-07-01 | 2025-06-30 | |
| 8-K | — | 2025-06-24 | — | |
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | — | |
| 8-K | — | 2025-03-14 | 2025-03-12 | |
| 8-K | — | 2025-03-11 | 2025-03-10 | |
| 8-K | — | 2025-03-11 | — | |
| 10-K | — | 2025-03-07 | 2024-12-31 | |
| 8-K | — | 2025-03-07 | — | |
| 8-K | — | 2025-03-05 | — | |
| S-3/A | — | 2024-12-30 | — | |
| S-3 | — | 2024-12-23 | — | |
| 8-K | — | 2024-12-04 | 2024-11-27 | |
| 10-Q | — | 2024-11-06 | 2024-09-30 | |
| 8-K | — | 2024-10-22 | 2024-10-16 | |
| 8-K | — | 2024-10-01 | 2024-09-27 | |
| ARS | — | 2024-08-16 | 2023-12-31 | |
| DEFA14A | — | 2024-08-16 | — | |
| DEF 14A | — | 2024-08-15 | — | |
| 8-K | — | 2024-08-09 | 2024-08-05 | |
| 10-Q | — | 2024-08-05 | 2024-06-30 | |
| 8-K | — | 2024-08-05 | — | |
| 8-K | — | 2024-07-19 | 2024-07-15 | |
| 8-K | — | 2024-07-12 | 2024-07-08 | |
| 8-K | — | 2024-06-20 | 2024-06-14 |
Showing 1–50 of 132 filings